Articles

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany;German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
Cardiff University School of Medicine, Cardiff, UK
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Massachusetts General Hospital, Boston, MA, USA
Laboratory of Hematology, André Mignot Hospital, Le Chesnay, France
Department of Hematology, Oncology and Tumor Immunology, Charité-University Medical Center, Campus Virchow Clinic, Berlin, Germany
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
4th Department of Internal Medicine-Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Králové, Hradec Králové, Czech Republic
Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
Université Paris-Saclay, Gustave Roussy Villejuif, France
Department of Medical & Molecular Genetics, King’s College London, Faculty of Life Sciences and Medicine, London, UK
Medical Clinic III for Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA;Department of Epidemiology, University of Washington, Seattle, WA, USA
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany;German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
Cardiff University School of Medicine, Cardiff, UK
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany
Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Internal Medicine I, University Hospital Carl-Gustav-Carus, Dresden, Germany
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK
NCT Trial Center, National Center for Tumor Diseases, Heidelberg, Germany
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2018.208678